Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Propranolol can cause reversible hair loss.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Paroxetine relieves pain by increasing allopregnanolone levels.

These medications for BPH have known risks and may have new side effects.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

SER120 nasal spray effectively reduces nighttime urination and is safe for patients.

Platelet-rich plasma (PRP) is an effective treatment for lichen planopilaris.

The effectiveness of platelet-rich plasma for erectile dysfunction is still unclear.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Metoprolol and propranolol may cause hair loss.

Valproic acid is effective for various seizures, but may cause temporary side effects like drowsiness and stomach issues.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Ruxolitinib can cause a delayed skin reaction on the nose.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.